According to the public information platform information of Maipu Regenerative Medicine Technology Co., Ltd., the company's main income in 2022 was 654.38+39 billion yuan, a year-on-year increase of 34.75%.
Guangzhou Maipu Regenerative Medicine Technology Co., Ltd. was established on September 2, 2008, which is an enterprise mainly engaged in technology promotion and application service industry.